Single Incision Laparoscopic Cholecystectomy (SILC)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The investigators aim to investigate the safety, feasibility and short-term outcomes of Single Incision Laparoscopic Cholecystectomy.
The investigators hypothesize that Single Incision Laparoscopic Cholecystectomy is safe and feasible.
| Condition | Intervention | Phase |
|---|---|---|
|
Cholelithiasis |
Procedure: Single Incision Laparoscopic Cholecystectomy |
Phase 1 |
| Study Type: | Interventional |
| Study Design: | Endpoint Classification: Safety/Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Single Incision Laparoscopic Cholecystectomy |
- Safety and feasibility [ Time Frame: 12 months ] [ Designated as safety issue: Yes ]
- Short-term clinical outcomes [ Time Frame: 12 months ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 20 |
| Study Start Date: | March 2008 |
| Study Completion Date: | December 2009 |
| Primary Completion Date: | December 2009 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Surgical group
Patients with ultrasound proven symptomatic cholelithiasis (gallstones).
|
Procedure: Single Incision Laparoscopic Cholecystectomy
A single trans-umbilical incision laparoscopic cholecystectomy will be performed by standard fashion and under general anesthesia.
Other Names:
|
Detailed Description:
Laparoscopic cholecystectomy is the standard approach for the treatment of gallbladder disease. Laparoscopic cholecystectomy is now performed as an outpatient procedure and it commonly requires the use of 4 separate small incisions. Single incision or single access trans-umbilical surgery may provide less pain, scarring and may improve patient's overall satisfaction.
In this phase I trial we aim to evaluate the safety, feasibility and short-term outcomes of Single Incision Laparoscopic Cholecystectomy for the treatment of symptomatic cholelithiasis (gallstones).
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Adults male and female(>18 years old)
- Capable of giving informed consent
- Ultrasound proven cholelithiasis
- Symptomatic cholelithiasis
- Elective cholecystectomy
Exclusion Criteria:
- Pregnancy
- Contraindications for general anesthesia
- Morbid obesity
- Multiple previous abdominal surgeries
- Uncontrolled medical conditions
- Acute cholecystitis
Contacts and Locations| United States, Texas | |
| UT Southwestern | |
| Dallas, Texas, United States, 75390 | |
| Principal Investigator: | Homero Rivas, MD | UTSouthwestern |
More Information
No publications provided
| Responsible Party: | Homero Rivas, UT Southwestern |
| ClinicalTrials.gov Identifier: | NCT00678873 History of Changes |
| Other Study ID Numbers: | 8843 |
| Study First Received: | May 14, 2008 |
| Last Updated: | December 14, 2009 |
| Health Authority: | United States: Federal Government |
Keywords provided by North Texas Veterans Healthcare System:
|
Single Incision Single Access Surgery Cholecystectomy |
Additional relevant MeSH terms:
|
Cholelithiasis Cholecystolithiasis Gallstones Biliary Tract Diseases |
Digestive System Diseases Gallbladder Diseases Calculi Pathological Conditions, Anatomical |
ClinicalTrials.gov processed this record on May 19, 2013